Cost-effectiveness of supplementary immunization for measles in India.
dc.contributor.author | Dabral, Mayank | |
dc.date.accessioned | 2013-01-09T05:00:25Z | |
dc.date.available | 2013-01-09T05:00:25Z | |
dc.date.issued | 2009-11 | |
dc.description.abstract | Objective: This study aims to estimate the incremental cost effectiveness of a supplementary immunization activity (SIA) for measles in a district of India with measles vaccine coverage equivalent to the National average. Design: A state transition model is used to estimate the effect of routine vaccination with measles vaccine as well as with measles vaccine during the SIA. The model follows each sub-cohort in the target population at respective age (1-5 years) to five years of age, using age specific incidence rate and vaccination rate to determine the number of cases of measles. Using age specific incidence rates and complication rates for measles; deaths and disability adjusted life year (DALY) averted is estimated. Results: Using base-case assumptions, an estimated 65479 cases of measles and 1637 deaths due to measles will be prevented in a span of four years from a single supplementary immunization activity in a pediatric population (1-5 years of age) of size 839,473. The cost per measles vaccine dose delivered is INR 30. Using base case analysis the cost to avert a death is INR 15381 and the cost per disability adjusted life year (DALY) averted is INR 430. Conclusions: Supplementary immunization activity for measles is cost-effective. However, this cannot be considered superior to a second dose of measles in routine immunization. | en_US |
dc.identifier.citation | Dabral Mayank. Cost-effectiveness of supplementary immunization for measles in India. Indian Pediatrics. 2009 Nov; 46(11): 957-962. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/144214 | |
dc.language.iso | en | en_US |
dc.source.uri | https://indianpediatrics.net/nov2009/nov-957-962.htm | en_US |
dc.subject | Cost-effectiveness | en_US |
dc.subject | India | en_US |
dc.subject | Measles | en_US |
dc.subject | Vaccine | en_US |
dc.subject | Supplementary immunization | en_US |
dc.subject.mesh | Child, Preschool | |
dc.subject.mesh | Cohort Studies | |
dc.subject.mesh | Cost-Benefit Analysis | |
dc.subject.mesh | Decision Trees | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Immunization, Secondary --economics | |
dc.subject.mesh | India | |
dc.subject.mesh | Infant | |
dc.subject.mesh | Measles --economics | |
dc.subject.mesh | Measles --prevention & control | |
dc.subject.mesh | Measles Vaccine --economics | |
dc.title | Cost-effectiveness of supplementary immunization for measles in India. | en_US |
dc.type | Article | en_US |